- Global Pharma News & Resources

Roche Holding AG Company Profile, Business Overview, Financial Performance, Operating Segments, Strategic Moves, and Competitive Intelligence Report –

Pune, Maharashtra, India, October 10 2022 (Wiredrelease) Prudour Pvt. Ltd –:Roche Holding AG is a Swiss multinational healthcare company that operates in over 170 countries. It is one of the world’s largest pharmaceutical companies and was founded in 1896. Roche is headquartered in Basel, Switzerland, and employs over 94,000 people worldwide. The company focuses on research-based pharmaceuticals and diagnostics, and its products include antidepressants, cancer treatments, and cholesterol-lowering drugs. In 2018, Roche’s revenue was over 59 billion Swiss francs (approximately $59 billion). Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, Revenue (US$ Mn), Operating Income (US$ Mn), Net Income (US$ Mn), SWOT Analysis, detailed reports on mergers and acquisitions (M&A), divestments, capital raising, venture capital investments, ownership and partnership transactions undertaken by Roche Holding AG Company – Mergers & Acquisitions (M&A), Partnerships & Alliances 

Key Financials
Revenue (US$ Mn)

US$ 69,941 Mn was Roche Holding AG’s annual revenue in 2021, an 8.41% increase from 2020 figures

Roche Holding AG indexed a 4.9% increase in annual revenues from 2019, amounting to US$ 64,515 Mn in 2020

Roche Holding AG generated total revenue of US$ 61,502 Mn in 2019

Annual revenue of US$ 57,150 Mn was indexed by Microsoft Corporation in 2018

Looking for Customized Insights to build your business for the future, Direct Buy:

Key Highlights

This report includes Roche Holding AG Company – Mergers & Acquisitions (M&A), Partnerships & Alliance’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Roche Holding AG Company – Mergers & Acquisitions (M&A), Partnerships & Alliances. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Reasons to buy

– Access comprehensive financial deals data along with charts and graphs covering M&A, private equity, and partnerships and alliances.

– Form an independent opinion about Roche Holding AG Company – Mergers & Acquisitions (M&A), Partnerships & Alliances’s growth strategies through the organic and inorganic activities.

– Track your competitor’s business structure and growth strategies.

Table of Contents


Key Financials


Mergers and Acquisitions – Deal reports


Corporate Venturing – Deal reports


Partnership – Deal reports


Capital Raising – Overview

Capital Raising – Deal reports

Divestments – Deal reports

Explore More Related Reports Here: 

Global Neurodiagnostics Market Segmentation and Forecast 2031

Global Molecular Biology Enzymes, Kits & Reagents Market Future Trends and Opportunities 2031

Global Lyophilized Injectable Drugs Market Developments, and Forecast 2022-2031

Global Proteinase K Market Research Methodology along with Key Financial Charts In 2022

Global Antibodies Market Annual Ratios | Demand and Forecast to 2031

Global Laboratory Benchtop Automation Market Price Trends, and Company Shares 2031

This content has been published by Prudour Pvt. Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 10-Oct-2022